\-\ Texto\\:\\ \ \(0\)\
\-\ slight\\ decreased\\ range\\ of\\ motion\\ when\\ compared\\ to\\ the\\ left\\ side\\.\ \(0\)\
\-\ a\\ trial\\ of\\ abduction\\ bracing\\ could\\ be\\ instituted\\ with\\ close\\ follow\\ up\\.\\ \\ treatment\\ of\\ pain\\ as\\ needed\\.\ \(0\)\
\-\ collapse\\ of\\ the\\ right\\ femoral\\ head\\ with\\ mixed\\ lucency\\ and\\ sclerosis\\ within\\.\\ \\ there\\ is\\ a\\ developing\\ coxa\\ cagna\\ breva\\ deformity\\ on\\ right\\ compared\\ to\\ the\\ normal\\ left\\ side\\.\ \(0\)\
\-\ legg\\-calve\\-perthes\ \(0\)\
\-\ avn\\ of\\ hip\\:\ \(0\)\
\-\ legg\\-calve\\-perthes\ \(0\)\
\-\ sickle\\ cell\\ disease\ \(41\)\
\-\ gaucher\\ disease\ \(1\)\
\-\ multiple\\ epiphyseal\\ dysplasia\ \(0\)\
\-\ cortico\\ steroid\\ use\ \(0\)\
\-\ 4\\ y\\/o\\ boy\\ with\\ chronic\\ right\\ hip\\ pain\\ with\\ which\\ is\\ progressively\\ worsening\\.\ \(1\)\
\-\ with\\ the\\ diagnosis\\ of\\ legg\\-calve\\-perthes\\,\\ approx\\.\\ 15\\%\\ can\\ be\\ bilateral\\.\\ \\ this\\ patient\\ will\\ then\\ need\\ follow\\-up\\ not\\ only\\ of\\ the\\ affected\\ side\\,\\ to\\ follow\\ its\\ progress\\ and\\ remodeling\\,\\ but\\ to\\ assess\\ the\\ opposite\\ side\\ for\\ any\\ evidence\\ of\\ involvement\\.\\ \\ this\\ patient\\ will\\ also\\ have\\ an\\ increased\\ risk\\ of\\ early\\ osteoarthritis\\ secondary\\ to\\ the\\ altered\\ mechanics\\ in\\ the\\ affected\\ hip\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ legg\\-calve\\-perthes\\:\\ 0\\.1194455051731792\ \(0\)\
\-\ side\\:\\ 0\\.0744766415538131\ \(0\)\
\-\ hip\\:\\ 0\\.0642240070209709\ \(0\)\
\-\ cagna\\:\\ 0\\.05544351210041823\ \(0\)\
\-\ breva\\:\\ 0\\.05544351210041823\ \(0\)\
\-\ cortico\\:\\ 0\\.05544351210041823\ \(0\)\
\-\ affected\\:\\ 0\\.04650974354150621\ \(0\)\
\-\ compared\\:\\ 0\\.04549712443648645\ \(0\)\
\-\ mechanics\\:\\ 0\\.0441745846209965\ \(0\)\
\-\ bracing\\:\\ 0\\.043205083490007457\ \(0\)\
\-\ coxa\\:\\ 0\\.043205083490007457\ \(0\)\
\-\ instituted\\:\\ 0\\.04036240975577439\ \(0\)\
\-\ gaucher\\:\\ 0\\.038005847180671175\ \(0\)\
\-\ avn\\:\\ 0\\.036925027954717346\ \(0\)\
\-\ opposite\\:\\ 0\\.03629557224052248\ \(0\)\
\-\ approx\\:\\ 0\\.034952338905314566\ \(0\)\
\-\ abduction\\:\\ 0\\.034486251030133926\ \(0\)\
\-\ follow\\:\\ 0\\.03415345247731364\ \(0\)\
\-\ remodeling\\:\\ 0\\.03405233359939838\ \(0\)\
\-\ trial\\:\\ 0\\.03384610829862486\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.03384610829862486\ \(0\)\
\-\ will\\:\\ 0\\.03362869205508355\ \(0\)\
\-\ altered\\:\\ 0\\.030473122707008662\ \(0\)\
\-\ progress\\:\\ 0\\.030355562122026565\ \(0\)\
\-\ sickle\\:\\ 0\\.029692917369461624\ \(0\)\
\-\ progressively\\:\\ 0\\.02890572779113454\ \(0\)\
\-\ steroid\\:\\ 0\\.028373920319259928\ \(0\)\
\-\ developing\\:\\ 0\\.028123981145363613\ \(0\)\
\-\ collapse\\:\\ 0\\.02750230922940995\ \(0\)\
\-\ assess\\:\\ 0\\.02693659704913989\ \(0\)\
\-\ need\\:\\ 0\\.02680277693311923\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.026671744940019594\ \(0\)\
\-\ close\\:\\ 0\\.026233506445441045\ \(0\)\
\-\ slight\\:\\ 0\\.02528130741113055\ \(0\)\
\-\ lucency\\:\\ 0\\.024686599344306573\ \(0\)\
\-\ mixed\\:\\ 0\\.023603291766915294\ \(0\)\
\-\ needed\\:\\ 0\\.023407347315470037\ \(0\)\
\-\ deformity\\:\\ 0\\.023142892999473186\ \(0\)\
\-\ range\\:\\ 0\\.021636729662153038\ \(0\)\
\-\ motion\\:\\ 0\\.02160767968821408\ \(0\)\
\-\ 15\\:\\ 0\\.021436142468593582\ \(0\)\
\-\ use\\:\\ 0\\.021241755440523917\ \(0\)\
\-\ dysplasia\\:\\ 0\\.021214469895878645\ \(0\)\
\-\ worsening\\:\\ 0\\.02116025138616854\ \(0\)\
\-\ femoral\\:\\ 0\\.02044652840656481\ \(0\)\
\-\ its\\:\\ 0\\.02028007197141913\ \(0\)\
\-\ could\\:\\ 0\\.01982740845176448\ \(0\)\
\-\ involvement\\:\\ 0\\.019697727400174947\ \(0\)\
\-\ early\\:\\ 0\\.0196550878593864\ \(0\)\
\-\ risk\\:\\ 0\\.01946670847395652\ \(0\)\
\-\ sclerosis\\:\\ 0\\.019303869392618522\ \(0\)\
\-\ then\\:\\ 0\\.01912557785171126\ \(0\)\
\-\ boy\\:\\ 0\\.018268690439785983\ \(0\)\
\-\ disease\\:\\ 0\\.017569025675669234\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.017484509380136744\ \(0\)\
\-\ right\\:\\ 0\\.017011919039819183\ \(0\)\
\-\ any\\:\\ 0\\.016923490774039585\ \(0\)\
\-\ be\\:\\ 0\\.016575556268477096\ \(0\)\
\-\ only\\:\\ 0\\.016159821751477583\ \(0\)\
\-\ decreased\\:\\ 0\\.015979600017135595\ \(0\)\
\-\ when\\:\\ 0\\.015392020362364816\ \(0\)\
\-\ head\\:\\ 0\\.015242775538200606\ \(0\)\
\-\ chronic\\:\\ 0\\.015138299578031447\ \(0\)\
\-\ secondary\\:\\ 0\\.015025345701313255\ \(0\)\
\-\ 4\\:\\ 0\\.014974666070308462\ \(0\)\
\-\ y\\/o\\:\\ 0\\.014884459307041766\ \(0\)\
\-\ cell\\:\\ 0\\.014517237179757775\ \(0\)\
\-\ up\\:\\ 0\\.014451868874554864\ \(0\)\
\-\ evidence\\:\\ 0\\.01409083385765332\ \(0\)\
\-\ to\\:\\ 0\\.013429814730911517\ \(0\)\
\-\ increased\\:\\ 0\\.013147703030186515\ \(0\)\
\-\ pain\\:\\ 0\\.01312714676139289\ \(0\)\
\-\ bilateral\\:\\ 0\\.013042878800719774\ \(0\)\
\-\ \\%\\:\\ 0\\.0125366102726164\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01234100208038\ \(0\)\
\-\ can\\:\\ 0\\.012190077688484716\ \(0\)\
\-\ this\\:\\ 0\\.012089776268102303\ \(0\)\
\-\ left\\:\\ 0\\.012026481374502072\ \(0\)\
\-\ have\\:\\ 0\\.011637975335629509\ \(0\)\
\-\ but\\:\\ 0\\.011462284912160614\ \(0\)\
\-\ multiple\\:\\ 0\\.011319534613077163\ \(0\)\
\-\ treatment\\:\\ 0\\.01087809408554017\ \(0\)\
\-\ patient\\:\\ 0\\.010774741269388528\ \(0\)\
\-\ also\\:\\ 0\\.010595091784089003\ \(0\)\
\-\ within\\:\\ 0\\.010252398794881016\ \(0\)\
\-\ which\\:\\ 0\\.010032355894607225\ \(0\)\
\-\ normal\\:\\ 0\\.00842523556351636\ \(0\)\
\-\ as\\:\\ 0\\.008129418276063697\ \(0\)\
\-\ there\\:\\ 0\\.007998211046949614\ \(0\)\
\-\ not\\:\\ 0\\.0077661551681882735\ \(0\)\
\-\ an\\:\\ 0\\.0074318544923567915\ \(0\)\
\-\ \\:\\:\\ 0\\.007108646641450724\ \(0\)\
\-\ is\\:\\ 0\\.007072839979682084\ \(0\)\
\-\ the\\:\\ 0\\.006955938853012619\ \(0\)\
\-\ of\\:\\ 0\\.006594554762150289\ \(0\)\
\-\ \\,\\:\\ 0\\.005107737085231837\ \(0\)\
\-\ a\\:\\ 0\\.0049886767524352366\ \(0\)\
\-\ for\\:\\ 0\\.004585585840520221\ \(0\)\
\-\ on\\:\\ 0\\.004552773662675648\ \(0\)\
\-\ with\\:\\ 0\\.0036793766066003063\ \(0\)\
\-\ in\\:\\ 0\\.002650297044907264\ \(0\)\
\-\ and\\:\\ 0\\.002264264223046773\ \(0\)\
\-\ \\.\\:\\ 0\\.0022326752262481933\ \(0\)\
